Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood

Environment International

Volumn 65, Issue , 2014, Pages 127-134

  Okada, Emiko ^a   Sasaki, Seiko ^a   Kashino, Ikuko ^a   Matsuura, Hideyuki ^b   Miyashita, Chihiro ^b   Kobayashi, Sumitaka ^a   Itoh, Kumiko ^a   Ikeno, Tamiko ^b   Tamakoshi, Akiko ^a   Kishi, Reiko ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Allergic diseases; Eczema; Perfluoroalkyl acids; Perfluorotridecanoic acid; Prenatal exposure

Indexed keywords

CHAINS; LIQUID CHROMATOGRAPHY; ORGANIC POLLUTANTS;

ALLERGIC DISEASE; ECZEMA; PERFLUOROALKYL ACIDS; PERSISTENT ORGANIC POLLUTANT (POP); PRENATAL EXPOSURE; SELF-ADMINISTERED QUESTIONNAIRE; TRIPLE QUADRUPOLE TANDEM MASS SPECTROMETRY; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY;

SURVEYS;

CHEMICAL COMPOUND; PERFLUOROALKYL ACIDS; PERFLUOROTRIDECANOIC ACID; PERFLUOROUNDECANOIC ACID; UNCLASSIFIED DRUG;

ALLERGY; CHILD HEALTH; HEALTH RISK; MATERNAL HEALTH; ORGANIC POLLUTANT; ORGANOFLUORINE; PLASMA; POLLUTION EFFECT; POLLUTION EXPOSURE; SKIN DISORDER; TOXICITY;

ADULT; ALLERGIC DISEASE; ARTICLE; BLOOD LEVEL; CHILDHOOD DISEASE; ECZEMA; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; PERFLUOROALKYL ACID BLOOD LEVEL; PERFLUOROTRIDECANOIC ACID BLOOD LEVEL; PERFLUOROUNDECANOIC ACID BLOOD LEVEL; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RHINOCONJUNCTIVITIS; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WHEEZING;

ALLERGIC DISEASES; ECZEMA; PERFLUOROALKYL ACIDS; PERFLUOROTRIDECANOIC ACID; PRENATAL EXPOSURE;

ADULT; CAPRYLATES; CHILD, PRESCHOOL; ECZEMA; FEMALE; FLUOROCARBONS; HUMANS; HYPERSENSITIVITY; INFANT; MALE; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84893191471     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2014.01.007     Document Type: Article

References (37)

1. Asher M.I., Montefort S., Björkstén B., Lai C.K., Strachan D.P., Weiland S.K. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
2. DeWitt J.C., Shnyra A., Badr M.Z., Loveless S.E., Hoban D., Frame S.R., et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 2009, 39:76-94.
3. DeWitt J.C., Peden-Adams M.M., Keller J.M., Germolec D.R. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 2012, 40:300-311.
4. Dong G.H., Tung K.Y., Tsai C.H., Liu M.M., Wang D., Liu W., et al. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect 2013, 121:507-513.
5. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res 2010, 110:773-777.
6. Fletcher T., Steenland K., Savitz D. Status Report: PFOA and immune biomarkers in adults exposed to PFOA in drinking water in the mid Ohio valley [(accessed 7 October 2013)]. http://www.c8sciencepanel.org/pdfs/Status_Report_C8_and_Immune_markers_March2009.pdf.
7. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 2009, 212:239-270.
8. Grandjean P., Andersen E.W., Budtz-Jørgensen E., Nielsen F., Mølbak K., Weihe P., et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 2012, 307:391-397.
9. Granum B., Haug L.S., Namork E., Stølevik S.B., Thomsen C., Aaberge I.S., et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 2013, [Online 25 January 2013]. 10.3109/1547691X.2012.755580.
10. Harada K.H., Yang H.R., Moon C.S., Hung N.N., Hitomi T., Inoue K., et al. Levels of perfluorooctane sulfonate and perfluorooctanoic acid in female serum samples from Japan in 2008, Korea in 1994-2008 and Vietnam in 2007-2008. Chemosphere 2010, 79:314-319.
11. Harada K.H., Hitomi T., Niisoe T., Takanaka K., Kamiyama S., Watanabe T., et al. Odd-numbered perfluorocarboxylates predominate over perfluorooctanoic acid in serum samples from Japan, Korea and Vietnam. Environ Int 2011, 37:1183-1189.
12. Ji K., Kim S., Kho Y., Paek D., Sakong J., Ha J., et al. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ Int 2012, 45:78-85.
13. Kashino I., Okada E., Sasaki S., Miyashita C., Ikeno T., Araki A., et al. Prenatal Exposure to 11 Perfluorinated Compounds (PFCs) and infant weight in the Hokkaido Study on Environmental and Children's Health. Environment and Health. Bridging South, North, East and West Conference of ISEE, ISES and ISIAQ. 19-23 August 2013, Basel, Switzerland 2013, 151. [ (accessed 7 October 2013)].
14. Keil D.E., Mehlmann T., Butterworth L., Peden-Adams M.M. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci 2008, 103:77-85.
15. Kishi R., Sasaki S., Yoshioka E., Yuasa M., Sata F., Saijo Y., et al. Cohort profile: The Hokkaido Study on Environment and Children's Health in Japan. Int J Epidemiol 2011, 40:611-618.
16. Kishi R., Kobayashi S., Ikeno T., Araki A., Miyashita C., Itoh S., et al. Ten years of progress in the Hokkaido birth cohort study on environment and children's health: cohort profile-updated 2013. Environ Health Prev Med 2013, 18:429-450.
17. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99:366-394.
18. Liao C., Wang T., Cui L., Zhou Q., Duan S., Jiang G. Changes in synaptic transmission, calcium current, and neurite growth by perfluorinated compounds are dependent on the chain length and functional group. Environ Sci Technol 2009, 43:2099-2104.
19. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int 2011, 37:1206-1212.
20. Martin J.W., Mabury S.A., Solomon K.R., Muir D.C.G. Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 2003, 22:196-204.
21. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 2007, 80:643-648.
22. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008, 108:56-62.
23. Ohmori K., Kudo N., Katayama K., Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 2003, 184:135-140.
24. Okada E., Sasaki S., Saijo Y., Washino N., Miyashita C., Kobayashi S., et al. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. Environ Res 2012, 112:118-125.
25. Okada E., Kashino I., Matsuura H., Sasaki S., Miyashita C., Yamamoto J., et al. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011. Environ Int 2013, 60:89-96.
26. Olsen G.W., Lange C.C., Ellefson M.E., Mair D.C., Church T.R., Goldberg C.L., et al. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ Sci Technol 2012, 46:6330-6338.
27. Peden-Adams M.M., EuDaly J.G., Dabra S., EuDaly A., Heesemann L., Smythe J., et al. Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid. Toxicol Environ Health A 2007, 70:1130-1141.
28. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006, 40:32-44.
29. Renner R. Scotchgard scotched-following the fabric protector's slippery trail to a new class of pollutant. Sci Am 2001, 284:18.
30. Sundström M., Ehresman D.J., Binert A., Butenhoff J.L., Olsen G.W., Chang S.C. A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden. Environ Int 2011, 37:178-183.
31. UNEP POPRC3: Development of Risk Management Evaluation; UNEP/POPS/POPRC.3/20 [(accessed 7 October 2013)]. http://chm.pops.int/Portals/0/Repository/poprc3/UNEP-POPSPOPRC.3-POPRC-3-5.English.PDF.
32. United States Environmental Protection Agency 2010/15 PFOA Stewardship Program [(accessed 7 October 2013)]. http://www.epa.gov/oppt/pfoa/pubs/stewardship/index.html.
33. Wang T., Wang Y.W., Liao C.Y., Cai Y.Q., Jiang G.B. Perspectives on the inclusion of perfluorooctane sulfonate into the Stockholm Convention on Persistent Organic Pollutants. Environ Sci Technol 2009, 43:5171-5175.
34. Wang I.J., Hsieh W.S., Chen C.Y., Fletcher T., Lien G.W., Chiang H.L., et al. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. Environ Res 2011, 111:785-791.
35. Wang M., Park J.S., Petreas M. Temporal changes in the levels of perfluorinated compounds in California women's serum over the past 50years. Environ Sci Technol 2011, 45:7510-7516.
36. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009, 117:660-667.
37. Wolf C.J., Takacs M.L., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol Sci 2008, 106:162-171.